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Background: Although many musicians perceive music performance anxiety (MPA) as a significant problem,
studies about the psychobiological and performance-related concomitants of MPA are limited. Using the
biopsychosocial model of challenge and threat as theoretical framework, we aim to investigate whether musicians’
changes in their psychobiological responses and performance quality from a private to a public performance are
moderated by their general MPA level. According to the challenge and threat framework, individuals are in a threat
state when the perceived demands of a performance situation outweigh the perceived resources, whereas they are
in a challenge state when the perceived resources outweigh the perceived demands. The resources-demands
differential (resources minus demands) and the cardiovascular challenge-threat index (sum of cardiac output and
reverse scored total peripheral resistance) are the main indices of these states. We postulate that the relationship
between general MPA level and performance quality is mediated by these challenge and threat measures.
Methods: We will test 100 university music students reporting general MPA levels ranging from low to high. They
will perform privately (i.e., without audience) and publicly (i.e., with an audience) on two separate days in
counterbalanced order. During each performance session, we will record their cardiovascular and respiratory activity
and collect saliva samples and self-reported measures. Measures of primary interest are self-reported anxiety, the
resources-demands differential, the cardiovascular challenge-threat index, sigh rate, total respiratory variability,
partial pressure of end-tidal carbon dioxide and the salivary biomarkers cortisol, dehydroepiandrosterone, and
alpha-amylase. Both, the participants and anonymous experts will evaluate the performance quality from audio
recordings.
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Discussion: The results of the planned project are expected to contribute to a more comprehensive understanding
of the psychobiology of MPA and of the processes that influence musicians’ individual reactions to performance
situations. We also anticipate the findings of this project to have important implications for the development and
implementation of theory-based interventions aimed at managing musicians’ anxiety and improving performance
quality. Thanks to the use of multimethod approaches incorporating psychobiology, it might be possible to better
assess the progress and success of interventions and ultimately improve musicians’ chance to have a successful
professional career.
Trial registration: Not applicable.
Keywords: Music performance anxiety, Biopsychosocial model, Challenge, Threat, Respiration, Cardiovascular
activity, Salivary cortisol, Salivary dehydroepiandrosterone, Salivary alpha-amylase, Music performance qualityBackground
Music performance anxiety (MPA) has been defined as «
the experience of marked and persistent anxious appre-
hension related to musical performance (…), which is
manifested through combinations of affective, cognitive,
somatic and behavioral symptoms » [1] , p. 433. MPA is
a significant problem for many musicians [2].
Performing publicly can be a psychophysiologically de-
manding activity for many musicians. Literature agrees
that on average, state anxiety is higher before and during
a public performance (i.e., in front of an audience or
jury) compared to a private performance (i.e., without an
audience or jury, e.g., [3, 4]). Compared to private per-
formances, public performances are also characterized
by enhanced physiological arousal in most musicians
(e.g., [5, 6]). Research on the psychophysiological con-
comitants of MPA is scant. With regard to their subject-
ive experience, general MPA level has been associated
with significant increases in state anxiety from a private
to a public performance [3, 7]. Regarding physiological
measures, skin conductance, heart rate (HR), urinary
adrenaline and noradrenaline did not show significant
differences as a function of musicians’ general MPA level
[3, 6, 8]. In contrast, analyses of the respiratory re-
sponses showed that the general MPA level significantly
moderated changes from a private to a public perform-
ance in partial pressure of end-tidal carbon dioxide
(PetCO2), total respiratory variability (quantified by the
coefficient of variation) and sigh rate [7, 8]. Salivary cor-
tisol (sC), salivary dehydroepiandrosterone (sDHEA),
and salivary alpha-amylase (sAA) have yet to be consid-
ered in relation to potential MPA-associated differences
in the context of music performance. The catabolic hor-
mone cortisol and the anabolic hormone dehydroepian-
drosterone (DHEA) are the main products of the
hypothalamic-pituitary-adrenal (HPA) axis, a central
regulatory system that in most healthy people is acti-
vated in response to psychosocial stressors, resulting in
increased sC and sDHEA secretion (e.g., [9–12]. Ana-
bolic balance is the ratio of DHEA to cortisol and hasbeen suggested to be a sensitive indicator of well-being
and health, more so than cortisol or DHEA alone [11,
13, 14]. Lower anabolic balance is associated with more
unfavorable psychological well-being and health out-
comes [14, 15]. SAA is an enzyme secreted from the sal-
ivary glands that has been increasingly used as a marker
of the activity of the sympathoadrenal-medullary (SAM)
axis, another important regulatory system involved in
the response to psychosocial stressors [16–18]. Re-
searchers have not investigated cardiovascular differ-
ences as a function of general MPA level other than for
HR and HR variability (HRV) [8].
Not all musicians have the same predisposition when
it comes to performing publicly; whereas some thrive,
others fail [19, 20]. The general MPA level was shown to
be a predictor of more negative self-rated performance
among music students performing solo [21]. Few studies
have evaluated whether musicians reporting relatively
lower and higher general MPA levels differ in their
expert-rated performance quality, and findings have
been mixed [3, 6, 22]. No study has yet tested simultan-
eously whether differences in both self-rated and expert-
rated performance quality between a private and a public
performance vary significantly as a function of musi-
cians’ general MPA level and what mechanisms might
explain such effects.
One theoretical framework that offers a potential
model to understand individual differences in psycho-
physiological responses and music performance quality
(MPQ) as a function of musicians’ general MPA level is
the biopsychosocial model (BPSM) of challenge and
threat [23, 24]. This model provides a framework for un-
derstanding the motivational processes within the con-
text of motivated performance situations. Motivated
performance situations, such as test taking, athletic com-
petitions, and music performances, are situations that re-
quire instrumental responses in order to attain valued
self-relevant goals [23, 25]. According to the BPSM of
challenge and threat, the self-relevance of the task-
related goals drives task engagement [25]. Given task
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states that a person can experience, depending on the
balance between her/his subjective evaluations of de-
mands and resources. Challenge occurs when evaluated
resources meet or exceed evaluated demands, whereas
threat arises when individuals evaluate demands as out-
weighing available resources. Challenge and threat are
understood as labels representing anchors of a single bi-
polar continuum defined by the resources-demands dif-
ferential, such that relative differences in challenge and
threat (e.g., greater vs. lesser threat) are meaningful [26].
A central tenet of the BPSM of challenge and threat is
that challenge and threat can be differentiated by means
of specific cardiovascular patterns. The current view is
that in the context of motivated performance situations,
HR and ventricular contractility (defined as pre-ejection
period (PEP) multiplied by − 1; PEP is the time in ms
from the initiation of left ventricle contraction to aortic-
valve opening) reflect task engagement proximally and
goal relevance distally and are common across the
challenge-threat continuum. Cardiac output (CO, the
amount of liters of blood pumped by the heart per mi-
nute) and total peripheral resistance (TPR, an index of
net constriction vs. dilation in the vascular system) dif-
ferentiate challenge and threat. Relatively larger values of
the cardiovascular challenge-threat index (CTI), defined
as the sum of CO and of reverse scored TPR, reflect
relatively greater challenge or lesser threat [24]. Com-
pared to threat, during challenge, arteries are more di-
lated/less constricted, which facilitates the heart
pumping relatively more blood. The cardiovascular pat-
tern of challenge is supposed to be more conducive to
approach-related goal pursuit, as blood delivery to the
brain and muscles is more efficient [25, 26]. These indi-
ces have been extensively validated [23, 27, 28]. The car-
diovascular patterns of challenge and threat have been
associated with more positive and negative health out-
comes, respectively [29–31].
Many studies have shown that individuals exhibiting a
cardiovascular challenge pattern prior to cognitive and
motor tasks perform better than individuals exhibiting a
cardiovascular threat pattern (e.g., [32–35]). Assessing
challenge and threat with cardiovascular measures, as
opposed to self-reports only, confers advantages because
this approach does not rely on individuals’ ability or will-
ingness to accurately report on their experiences, par-
ticularly given that nonconscious and irrational
influences are affecting them [36, 37]. Furthermore, car-
diovascular challenge-threat indices better predict per-
formance than self-reported variables [28, 32, 38, 39],
thus further highlighting the usefulness of these physio-
logical parameters. Most studies on the link between
challenge/threat states and task performance have used
a between-group design. A within-person design canmore conclusively show that cardiovascular activity pre-
dicts performance quality by excluding the alternative
hypothesis that individuals who possess greater ability at
a task are more likely to react with a challenge state [28,
40]. Anxious pianists reported lower expectations of be-
ing able to complete several tasks relating to piano per-
formance than non-anxious pianists [3], suggesting that
increasing levels of MPA might be associated with
greater threat/lesser challenge.
The aim of this study is to investigate in university
music students (1) whether the differences in their psy-
chophysiological responses and in their MPQ between a
private performance and a public performance vary sig-
nificantly as a function of their general MPA level and
(2) whether the cardiovascular CTI and the resources-
demands differential are significant mediators of the re-
lationship between the general MPA level and the MPQ.
We aim to test the following hypotheses:
1. Relationship between general MPA level and
challenge-threat. Higher general MPA level is
associated with greater increase in threat from the
private to the public performance: With increasing
general MPA level, change scores (public minus
private) of the cardiovascular CTI and the
resources-demands differential (self-rated resources
minus self-rated demands) decrease.
2. Relationship between general MPA level and MPQ.
Higher general MPA level is associated with greater
decrease in self-rated and expert-rated MPQ from
the private to the public performance: With increas-
ing general MPA level, change scores (public minus
private) of self-rated and expert-rated MPQ decrease.
3. The mediating role of challenge-threat. The
cardiovascular CTI and the resources-demands dif-
ferential are significant mediators of the relation-
ships between general MPA level and self-rated and
expert-rated MPQ.
4. Relationship between general MPA level and state
anxiety. Higher general MPA level is associated
with greater increase in state anxiety from the
private to the public performance: With increasing
general MPA level, change scores (public minus
private) of state anxiety increase.
5. Relationship between general MPA level and
respiration. Higher general MPA level is associated
with greater increase in sigh rate and total
respiratory variability and greater decrease in
PetCO2: With increasing general MPA level, change
scores (public minus private) of sigh rate and total
respiratory variability increase, whereas change
scores of PetCO2 decrease.
6. Relationship between general MPA level and
salivary measures of HPA axis activity and SAM
Fig. 1 Study protocol
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with greater increase in sC and greater decrease in
sDHEA, anabolic balance and sAA: With increasing
general MPA level, change scores (public minus
private) of sC increase, whereas change scores of
sDHEA, anabolic balance and sAA decrease.
Methods/design
Participants
Participants will be university music students recruited
from university music schools by means of electronic in-
vitations and posting on social media. Based on sample
size estimations (see chapter Sample size calculation),
we aim to collect complete data from 100 students.
Participants will have to be students in the department
of classical music, between 18 and 35 years of age and in
general good health. Exclusion criteria are cardiovascu-
lar, neurologic, respiratory and endocrine diseases, and
the use of drugs with effects on the cardiovascular, ner-
vous, respiratory and endocrine systems, including recre-
ational drugs, beta-blockers and anxiolytic medication.
Individuals wearing a pacemaker and working night
shifts will also be excluded. A current diagnosis of panic
disorder or eating disorders are additional exclusion cri-
teria. Women will be excluded if they are pregnant or
lactating. Eligibility to participate will be determined
with an entry online questionnaire. Participants will re-
ceive 250 Swiss Francs as compensation if they complete
all phases of the study protocol.
Study protocol
Participation in the study consists of completing an
entry online questionnaire, attending three laboratory
sessions (Habituation session, Performance session 1,
Performance session 2) and completing a final online
questionnaire (Fig. 1). The study is conducted in French
or English depending on participants’ preference.
Entry online questionnaire
In the entry online questionnaire, we will collect socio-
demographic, academic, music and health-related data
as well as the students’ general MPA level. Eligible par-
ticipants will be contacted to arrange three appoint-
ments (Habituation session, Performance session 1, and
Performance session 2). The two performance sessions
will be scheduled ensuring that the participants have no
other public performances neither on the same day of
the performance session, nor the day before, or after it.
Habituation session
Participants will be tested individually. Upon arrival to
the lab, the experimenter will explain the study protocol
to the participant and obtain written consent. This will
be followed by the measurement of participant’s bodyheight and weight, which are used to compute the body
mass index (BMI). Afterwards, the participant will be fa-
miliarized with the physiological measurements. The ex-
perimenter will show the different instruments and
explain their function. Afterwards, the sensors of the
four devices Finometer, VU-AMS, BioRadio and Capno-
stream will be applied, and the participant will be asked
to sit for 8 min alone. After removing the sensors of the
Finometer and the Capnostream, the participant will be
invited to play his/her instrument for a few minutes. In-
formation about the comfort level regarding the sensors
during the two periods will be obtained, and adjustments to
the sensors will be made if required. The participant will
also be familiarized with the saliva sampling procedure.
In the second part of the habituation session, the par-
ticipant will be presented with a list of instrument spe-
cific music pieces from which he/she will have to choose
one to perform during the following performance ses-
sions. The pieces belong to the standard repertoire usu-
ally required for auditions, competitions and exams. The
duration of the pieces is between 3min and 4min and
30 s (e.g., first 4 min of the solo parts of the clarinet con-
certo in A major, K. 622 by W.A. Mozart). We will pro-
vide the participants with the exact number of bars to
perform and require them to perform the selected pieces
by heart and without accompaniment during the two
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days to choose their music piece. Finally, the experi-
menter will give the participant the following informa-
tion about the upcoming performance sessions: the
session order (private before public session or vice versa)
and the audience composition (composed of the experi-
menter and five to seven music connoisseurs including
two experts who will rate their MPQ). The experimenter
will also explain the MPQ Scale to them.
Private and public performance sessions
One month after the habituation session, the participant
will come to our laboratory for the two performance ses-
sions. For each participant, the two sessions will take
place 2 days apart (e.g., Monday and Wednesday) at the
same time of the day. Participants will be scheduled at
either 1 pm or 3.45 pm. The procedures of the two ses-
sions are identical, except for the fact that the partici-
pants will perform without audience in the private
session and in front of an audience of six to eight per-
sons in the public session. Participants are randomly
assigned to one of the two possible orders. The proced-
ure of a performance session is shown in Fig. 2.
The day before each performance session, the partici-
pants will receive an electronic reminder in which they
are asked to comply with the following requirements: no
alcohol intake and no intense physical activity 24 h be-
fore the visit, no heavy meal 1h15min before the visit,
no caffeine intake (including coffee, tea or chocolate)Fig. 2 Performance session procedure – (Q = Questionnaire; S = Salivary sam
participants are sitting alone at a table and required to keep their hands on
their legs. Q1 consists of questions assessing participants’ compliance with
questionnaires CSAI-2R (cognitive anxiety, somatic anxiety, self-confidence)
the questionnaires FSS-2, MPQ Scale, CSAI-2R (somatic anxiety), self-reporte
questionnaires CSAI-2R (somatic anxiety), STAI-6 and SAMq. Q6 includes th
Performance Thoughts Questionnaire, a question about performance enga1h15min before the visit, no cigarettes or any products
containing nicotine 1 h before the visit, and no food in-
take 15min before the visit. The email for the public
performance session will also remind the participants of
the audience composition.
First, participants will be given 5 min to prepare their
instrument and warm up. Then, they will fill in a first
questionnaire (Q1) to verify their compliance with the
behavioral instructions (food intake, etc.). After attach-
ing the sensors of the Finometer, VU-AMS, BioRadio
and Capnostream and performing the required checks
and calibrations, a first saliva sample (S1) will be col-
lected followed by an 8-min period during which the
participants will be sitting alone at a table and re-
quired to keep their hands on the table, keep their
eyes open, stay quiet and still and not cross their
legs. Afterwards, participants will fill in a second
questionnaire (Q2) and take a second saliva sample
(S2). Following the removal of the sensors of the Fin-
ometer and of the Capnostream, the participants will
perform their music piece. After the performance, the
participants will fill in a third questionnaire (Q3) and
take a third saliva sample (S3). The rest of the session
will consist of three 5-min sitting periods each
followed by questionnaires (Q4, Q5, Q6) and saliva
collection (S4, S5, S6). The timing of the sitting pe-
riods, performance, questionnaires, and saliva collec-
tion, as well as the content of each questionnaire are
given in Fig. 2.ple) The quiet sitting periods correspond to a period where the
the table, keep their eyes open, stay quiet and still and not cross
the behavioral instructions (food intake, etc.) Q2 includes the
, self-reported demands and resources, STAI-6 and SAMq. Q3 includes
d demands and resources, STAI-6 and SAMq. Q4 and Q5 include the
e questionnaires CSAI-2R (somatic anxiety), STAI-6, SAMq, Post-Music
gement and a question about practice time.
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Zoom H4 (Zoom North America, Hauppauge, NY, USA)
placed on a tripod close to the participant. It will be
combined with a microphone DPA 4099 (DPA Micro-
phones, Inc., Longmont, CO, USA), which will be placed
on the participant’s instrument with a clip or on a music
stand depending on participant’s preferences (only on a
music stand for singers). Audio recording will be started
and stopped by the experimenter while participants are
completing questionnaire Q2 and Q3, respectively.Final online questionnaire
One week after completing the second performance ses-
sion, participants will receive the recordings of their two
performances via an e-mail containing a link to a final
online questionnaire and a Dropbox link to two mp3
audio files named “Recording1” for the first performance
session and “Recording2” for the second performance
session. In the online questionnaire, participants will be
asked to listen to these audio files in the same order and
rate the MPQ using the MPQ Scale.
Finally, the participant will fill in questionnaires asses-
sing their trait anxiety, social anxiety and depressive
symptoms, all of which are potential confounding vari-
ables because they can affect the psychophysiological
measures.Music performance quality evaluated by anonymous
experts
Upon termination of the experiments with all partici-
pants, the audio recordings will be sent to music experts
for evaluation of the performances using the MPQ Scale.
The experts will be professional musicians/teachers with
a minimum requirement of master’s level training on
their main performance instrument and with experience
of professional assessment and adjudication (see [41–43]
for similar criteria). They will have no association with
the participants. We will have five judges per instrument
type [44, 45]. In order to minimize the influence of non-
musical factors on the evaluations [46, 47], judges will
receive the recordings in an individually randomized
order, work independently and be unaware of the condi-
tions under which performances were recorded and of
any personal data about the participants.Measures of the online entry questionnaire
Sociodemographic data
The sociodemographic data include age, gender, mother
tongue, French or English level (on a scale from 1 = Do
not speak and do not understand English/French to 5 =
Speak and understand perfectly English/French), and
night shift work (yes/no).Academic and music-related data
The academic and music-related data include the name
of the school, the department, the current academic
year, the main instrument, the time they started to play
their main instrument, the second instrument, the aver-
age number of hours per day of music practice, the
number of public solo and ensemble performances given
during the past 12 months.
Health-related data
We will ask participants to list any known disease and
any acute or chronic medication intake and to answer
the questions assessing panic disorder and eating disor-
ders from the Patient Health Questionnaire (for English
version [48]; for French version [49]). Women will be
also asked to indicate whether they are pregnant, lactat-
ing or using hormonal contraceptives. Women will also
indicate the first day and the length of their last period
as well as the duration of their menstrual cycle. More-
over, participants will have to indicate if they wear a
pacemaker, smoke or take recreational drugs.
General MPA level
The general MPA level will be assessed with the state
scale of the State-Trait Anxiety Inventory (STAI-S; for
English version [50], for French version [51]), which
consists of 20 items, e.g., “I am tense,” rated on a 4-
point Likert scale (1 “not at all” to 4 “very much so”).
The score ranges from 20 (no anxiety) to 80 (severe anx-
iety). Because anxiety depends on the performance set-
ting [52], we will ask students to indicate how they
generally feel when they perform solo. We [8, 21] and
others [e.g., [53, 54, 55]] have used this instrument to as-
sess the general MPA level. The internal consistency of
this questionnaire is excellent (Cronbach’s alpha > .90
[8, 21]).
The Kenny Music Performance Anxiety Inventory-
Revised (for English version [56], for French version
[57]) will be used as a complementary measure to the
STAI-S. This questionnaire consists of 40 items evaluat-
ing eight MPA-related dimensions (proximal somatic
anxiety and worry about performance, worry/dread fo-
cused on self/other scrutiny, depression/hopelessness,
parental empathy, memory, generational transmission of
anxiety, anxious apprehension and biological vulnerabil-
ity). Each item is rated on a 7-point Likert scale (0
“Strongly disagree” to 6 “Strongly Agree”). The score can
vary from 0 (no anxiety) to 240 (severe anxiety). The
psychometric properties of this questionnaire are good
[58].
Performance session measures
For the measures assessed during the two performance
sessions, we distinguish between primary and secondary
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hypotheses. Secondary measures are assessed and ana-
lyzed for exploratory purposes.
Cardiovascular measures
Cardiovascular measures will be recorded and analyzed
following international guidelines [59–61]. The VU-
AMS (Free University, Amsterdam, The Netherlands)
will be used to obtain impedance cardiographic and elec-
trocardiographic recordings by applying seven electrodes
on specific positions of participants’ thorax and back.
We will analyze the data with the VU-AMS Data, Ana-
lysis & Management Software (Free University,
Amsterdam, The Netherlands). The Finometer (FMS
Finapres Medical Systems, Amsterdam, The
Netherlands) will be used to record blood pressure (BP)
beat-to-beat by finger-cuff photoplethysmography. A fin-
ger cuff is wrapped around the middle phalanx of the
middle finger of participants’ left hand. A hydrostatic
height correction of the finger with respect to the heart
level is active during the entire recording. The Fin-
ometer recordings will be analyzed with the Beatscope
software (FMS Finapres Medical Systems, Amsterdam,
The Netherlands). Beat-to-beat BP recording is a signifi-
cant advancement from the more often used single BP
readings. The finger cuff will not be used during the per-
formance, as it would interfere with performing. The
primary cardiovascular measure is the CTI defined as
the sum of CO and reverse scored TPR [33]. HR, HRV,
stroke volume, systolic BP, diastolic BP, mean arterial
pressure, CO, TPR and PEP are secondary cardiovascu-
lar measures.
Respiratory measures
Respiratory inductive plethysmography (RIP) sensors of
the BioRadio (Great Lakes NeuroTechnologies, OH,
USA) will be used to measure breathing parameters.
This system consists of a thoracic band and an abdom-
inal band that provide thoracic and abdominal motion
signals, respectively. The proportionality constant be-
tween the thoracic and abdominal motion signals is de-
termined by the qualitative diagnostic calibration
method [62]. The RIP bands will be volume-calibrated
using a spirometer (Vernier Software & Technology,
Beaverton, OR, USA) at the beginning of each recording.
The BioRadio recordings will be analyzed with the Vivo-
sense software (Vivonoetics, Newport Beach, CA, USA).
PetCO2 will be recorded by means of a nasal cannula
connected to a nondispersive infrared CO2 monitor
(Capnostream 35, Medtronic, Switzerland). The nasal
cannula will not be used during the performance, as it
would interfere with performing. The primary respira-
tory measures are sigh rate, total respiratory variability
and PetCO2. Secondary respiratory measures includemeans of inspiratory time, expiratory time, total breath
duration, tidal volume and minute ventilation. An em-
bedded motion sensor in the BioRadio will record tri-
axial acceleration and angular velocity to quantify
movement, both of which could affect other physio-
logical measures.
Salivary measures
Saliva samples will be obtained via a passive drooling
method facilitated by polypropylene straws into low-
bind polypropylene 2 mL cryovials (Salicap, IBL Inter-
national, Hamburg, Germany). For each saliva sample,
participants will be instructed to rinse their mouth with
water, swallow the saliva currently in their mouth, accu-
mulate new saliva for 2 min and then transfer all saliva
into the tubes. Samples will be stored immediately after
collection at − 20 °C and then shipped on dry ice to the
Biochemical Laboratory of the Department of Clinical
Psychology, University of Vienna headed by Prof. U.M.
Nater, where they will be assayed for free cortisol and
DHEA using immunoassay kits and for sAA using en-
zyme kinetic assay kits. SC, sDHEA and sAA are primary
measures.
Self-reported demands and resources
Self-reported demands will be assessed before the per-
formance (Q2) with the question “How demanding do
you expect this music performance to be?” and after the
performance (Q3) with the question “How demanding
was the music performance situation?”. Self-reported re-
sources will be assessed before the performance (Q2)
with the question “How able are you to cope with the
demands of the music performance?” and after the per-
formance (Q3) with the question “How able were you to
cope with the demands of the music performance situ-
ation?”. The participants will answer using a 6-point
Likert scale ranging from 1 “not at all” to 6 “extremely”.
These questions are adapted from the cognitive appraisal
ratio [63, 64]. The resources-demands differential is the
primary measure obtained by subtracting the score of
the first question from the score of the second question.
The self-reported demands and self-reported resources
analyzed separately are secondary measures.
State anxiety
Self-rated state anxiety is a primary measure assessed be-
fore and after each performance (Q3 to Q6) with the 6-
item version of the STAI (STAI-6; example item: “I am
tense”), which yields results that are comparable to those
obtained using the full-form [65]. Each item is rated on
4-point Likert scale (1 “not at all” to 4 “very much so”)
and a sum score of all items is computed. Higher scores
indicate greater state anxiety.
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MPQ is a primary measure assessed after each perform-
ance (Q3) with the MPQ Scale (See Additional file 1).
This scale is a revised version of a MPQ scale used in a
previous study [21]. The scale consists of nine dimen-
sions (“tempo”, “rhythm”, “intonation”, “tone”, “dynam-
ics”, “articulation”, “musical understanding and
interpretation”, “missing notes, wrong notes and unwrit-
ten breaks” and “global appreciation”) to be rated on a
21-point scale ranging from 1 (= lowest score) to 6 (=
highest score), with 0.25-point intervals to replicate the
grading system of French-speaking Swiss schools. A def-
inition is given for each dimension together with the
specific aspects to consider in scoring the dimension. As
done previously [21], we will compute an average score
of these dimensions with higher scores corresponding to
better MPQ.
Cognitive anxiety, somatic anxiety and self-confidence
Cognitive anxiety, somatic anxiety, and self-confidence
are secondary measures. Cognitive anxiety and self-
confidence will be assessed before each performance
(Q2), whereas somatic anxiety will be assessed before
and after each performance (Q2 to Q6) with the Com-
petitive State Anxiety Inventory – 2 Revised (CSAI-2R;
for English [66], for French [67]). Five items (e.g., “I am
concerned about performing poorly”) assess cognitive
anxiety, seven items (e.g., “My heart is racing”) assess
somatic anxiety and five items (e.g., “I’m confident of
coming through under pressure”) assess self-confidence.
Intensity of each item is rated on a 4-point Likert scale
(1 = “not at all” to 4 = “very much so”). We have chan-
ged the instructions to make the inventory applicable to
music performance and the internal consistency of this
questionnaire is good (Cronbach’s alpha > .80 [68]).
Arousal, valence, control
The affective dimensions arousal, valence, and control
are secondary measures assessed with the Self-
Assessment Manikin (SAMq; for English version [69],
for French version [70]) before and after each perform-
ance (Q2 to Q6). The SAMq consists of five manikins
for each affective dimension. Each dimension is scored
on a 5-point scale. Arousal ranges from 1 (low arousal)
to 5 (high arousal). Valence ranges from 1 (negative
valence) to 5 (positive valence). Control ranges from 1
(not in control) to 5 (in control).
Flow
Flow refers to the subjective experience of being
immersed and absorbed in an activity and is suggested
to be a state of consciousness that is conducive to high
levels of performance. In this study, it is a secondary
measure assessed after each performance (Q3) with theFlow State Scale-2 (FSS-2) (for English [71], for French
[72]). It consists of 36 items, with four items for each of
nine dimensions (“challenge-skill balance”, “merging of ac-
tion and awareness”, “clear goals”, “unambiguous feedback”,
“concentration on the task at hand”, “sense of control”, “loss
of self-consciousness”, “transformation of time” and “auto-
telic experience”). Respondents indicate the extent to which
they agree with each statement on a 5-point Likert scale
from 1 “strongly disagree” to 5 “strongly agree” by referring
to the just completed performance. Higher scores reflect
more intense flow. The internal consistency of this ques-
tionnaire is good (Cronbach’s alpha >.80 [71]).
Negative and positive post-music performance thoughts
Negative and positive post-music performance thoughts
are secondary measures assessed after each performance
(Q6) with the 23-item Post-Music Performance
Thoughts Questionnaire [21] adapted from the Post-
Event Rumination Questionnaire for public speech [73].
The questionnaire is divided into nine positive items
(e.g., “My concert was good”) and 14 negative items
(e.g., “I made a lot of mistakes”). Participants will be
instructed to report to what extent they had each
thought on mind since the end of the performance using
a 5-point Likert scale ranging from 0 “not at all” to 4
“extremely”. The positive items score varies from 0 (no
positive thoughts) to 36 (a lot of positive thoughts), and
the negative items score varies from 0 (no negative
thoughts) to 56 (a lot of negative thoughts). Internal
consistencies of both scales are excellent [21].
Task engagement
The engagement in the task is a secondary measure
assessed at the end of each performance session (Q6)
with the question “To what extent did you try to give
the best of yourself during the performance?”. Partici-
pants will answer using a 5-point Likert scale ranging
from 1 “not at all” to 5 “very much so”.
Practice time
The amount of practice time for each session perform-
ance is a secondary measure assessed at the end of each
performance session (Q6) with the question “How much
time have you spent in the last 48 hours specifically pre-
paring the musical piece you have just played?”. Partici-
pants will respond by indicating a numerical value.
Measures of the final online questionnaire
Trait anxiety Trait anxiety will be assessed with the
trait scale of the State-Trait Anxiety Inventory for adults
(for English version [50], for French version [51]. This
questionnaire consists of 20 items (example item: “I am
a steady person”) that are rated on a 4-point Likert scale
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ranges from 20 to 80, with higher scores indicating
greater trait anxiety. The test has good psychometric
properties [50, 74].
Social anxiety Social anxiety will be assessed with the
self-reported version of the Liebowitz Social Anxiety
Scale (for English version [75, 76], for French version
[77]). This scale quantifies fear and avoidance of social
interaction situations (12 items, e.g., “Calling someone you
do not know very well”) and performance situations (12
items, e.g., “Acting, performing or giving a talk in front of
an audience”) during the last week. The possible responses
for experienced fear are 0 (none), 1 (mild), 2 (moderate),
or 3 (severe), and the possible responses for avoidance be-
havior are 0 (never), 1 (occasionally), 2 (often), or 3 (usu-
ally). The total score can range from 0 to 144 with higher
scores indicating greater social anxiety. The test possesses
good psychometric properties [78].
Depressive symptoms Depressive symptoms will be
assessed with the Beck Depression Inventory-II (for Eng-
lish version [79], for French version [80]). This inventory
is a unipolar questionnaire assessing depressive symp-
toms during the last 2 weeks with 21 items. Each item
contains four sentences, which are coded from 0 (less
close to depression, e.g., “I do not feel sad”) to 3 (closest
to depression, e.g., “I am so sad or unhappy that I can’t
stand it”). The total score can range from 0 to 63 with
higher scores indicating more severe depressive symp-
toms. The test has good psychometric properties [79].
Data-analytic strategy
Scores for self-report measures will be computed in ac-
cordance with guidelines. For cardiovascular and respira-
tory measures, scores will be computed for the 8-min
sitting period, the 4-min performance period, and the
three 5-min post-performance sitting periods, with focus
on the 8-min sitting period, as this is the most relevant
period with regard to our hypotheses. The area under
the curve with respect to ground and to increase will be
calculated for the salivary parameters [81].
Given the repeated measures design, we will use multi-
level mixed-effects modeling following state of the art
procedures [82, 83]. For the mediation analyses, we will
follow the model suggested by Baron and Kenny [84].
The main predictors are performance session (private vs.
public), general MPA level and their interaction. Where
appropriate, skewed variables will be transformed. We
will use an alpha level of 0.05 for all tests. We will
perform sensitivity analyses adding control variables to
the models if they are theoretically meaningful and sig-
nificantly related to the outcome variable. Potential con-
trol variables are age, gender, use of hormonalcontraceptives, menstrual cycle phase, BMI, smoking,
trait anxiety, social anxiety, depressive symptoms, aca-
demic year, practice time, session order, and motion.
Sample size calculation
The sample size calculation refers to the first three sets
of hypotheses, which we consider to be the critical ones.
The power computations are based on a model by which
the effect of general MPA level on MPQ follows two
paths, direct and indirect. In the indirect path, MPA acts
on the cardiovascular CTI, which acts on MPQ. The
computations rely on the repeated simulations of such a
model. First, we fix the distributional parameters of
MPA. We obtained a mean (M) of 45 on the STAI-S
scale and a standard deviation (SD) of 12 [8]. We assume
that general MPA level influences deltaCTI, i.e., the dif-
ference in CTI between private and public performance
sessions. To simulate realistic values for deltaCTI, we
rely on [85] who reported a difference in the cardiovas-
cular CTI between a “challenge” group and a “threat”
group of 0.9. Thus, we assume M = 0.9 for deltaCTI.
Moore et al. [85] used a two-group design, while we use
a repeated-measures design. To estimate SD of deltaCTI,
we rely on [8] who used a similar design as in the
planned project. In their study, M and SD of deltaHR be-
tween private and public sessions were 28 and 16, re-
spectively. Assuming similar coefficients of variation for
deltaHR and deltaCTI, we obtain SD = 0.9*16/28 = 0.5
for deltaCTI. From knowledge about distributions of
general MPA level and deltaCTI and assuming normal
distributions and linear relationships, we can deduce the
equation of the linear regression from the following vari-
ance components: Var(deltaCTI) = variance of deltaCTI,
VarRes = residual variance, Var(MPA) = variance of MPA.
The slope betadeltaCTI_MPA is the square root of (Var(del-
taCTI) – VarRes)/Var(MPA), and the intercept is mean
(deltaCTI) - betadeltaCTI_MPA*mean(MPA). Defining the
effect size using Cohen’s [86] η2, where η2 = (Var(del-
taCTI)-VarRes)/ Var(deltaCTI), the model relating MPA
and deltaCTI is specified. Next, we specify the effect of
deltaCTI on deltaMPQ, where deltaMPQ is the differ-
ence in MPQ between public and private performance
sessions. We assume a linear relationship with slope
betadeltaMPQ_deltaCTI. Without any loss of generality, we
can specify the linear relation without intercept and with
residual SD = 1. Thus, the indirect effect of MPA on del-
taMPQ is betaindir = betadeltaCTI_MPA*betadeltaMPQ_deltaCTI.
Next, we assume that there is also a direct effect given
by the slope betadir, which is determined by the assumed
mediated proportion (MP): betadir = betadeltaCTI_MPA*be-
tadeltaMPQ_deltaCTI*(1-MP)/MP. In summary, given a
simulation of MPA, we simulate deltaCTI and del-
taMPQ = betadeltaMPQ_deltaCTI *deltaCTI + betadir*MPA +
e, e ~ N(0,1). Finally, we define that small-to-medium
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MPA on deltaMPQ, MPA on deltaCTI and deltaCTI on
deltaMPQ and MP between 20 and 30% are scientifically
meaningful. By running 10′000 simulations of the afore-
mentioned model with different combinations of the pa-
rameters, we determine that these effects are significant
at α = 0.05 and power > 0.80 with a sample of 100
participants.
Discussion
The findings of this study will allow us to determine to
what extent MPA can be examined and understood from
the perspective of the BPSM of challenge and threat and
to what extent the BPSM of challenge and threat is a
valid and useful framework by which performance vari-
ability can be examined, understood, and predicted in
the domain of music performance. Furthermore, by in-
vestigating both psychophysiological and performance-
related concomitants of a form of anxiety that has so far
received relatively little attention, this study will add new
and important information that will contribute to the
issue of generalizability of findings across subtypes of so-
cial anxiety (disorder) and anxiety (disorders) more
broadly. We also anticipate the outcomes of this study
to contribute significantly to guiding the development
and implementation of theory-based interventions aimed
at managing musicians’ anxiety and improving perform-
ance quality. Psychophysiological monitoring adds an
important dimension to the diagnostic and intervention
outcome assessments. Thanks to the use of multimethod
approaches incorporating psychobiology, it might be
possible to better assess the progress and success of in-
terventions and ultimately improve musicians’ chance to
have a successful career. Within these approaches, re-
spiratory regulation may play a significant role. Breath-
ing is a powerful regulator of homeostatic balance and
can be controlled voluntarily making breathing modifica-
tion an accessible intervention goal. Breathing modifica-
tion might be an integral part of interventions aimed at
promoting challenge states over threat states. Given that
the cardiovascular response pattern characterizing a
threat state is considered to have deleterious health con-
sequences when experienced frequently, such interven-
tions may also have health-related implications. Finally,
motivated performance situations are pervasive, in par-
ticular in the workplace. Thus, we expect the results of
this study to have implications that extend beyond the
domain of music performance.
Possible challenges
We are conscious that this project is ambitious and that
we might face several challenges. We discuss three of
them. A first challenge would be having a similar num-
ber of male and female participants to avoid a genderbias. Previous studies on the same population [7, 21]
showed that, on average, 60 to 67% of the sample were
female. Having a well-balanced gender ratio is important
considering gender differences in the prevalence of anx-
iety disorders [87, 88] and especially of MPA [2], and in
the psychophysiological response to stressors [89]. The
second challenge that we might face is related to
women’s menstrual cycle phase. The monthly fluctuation
in the levels of steroid hormones in women affect their
psychophysiology (e.g., [90–93]). Following previous re-
search [14, 94], we will control for these effects by test-
ing female participants during the first 7 days after
menstruation (follicular phase). To achieve this, we will
collect information about the first day of the last men-
strual cycle, the typical duration of the period, and of
the entire cycle. We will use this information to schedule
the appointments for the performance sessions. How-
ever, women’s menstrual cycle is not always regular,
making it hard to correctly predict the right period to
book an appointment, especially one or 2 months in ad-
vance. A final challenge we might face relates to any ob-
stacles that could interfere with the smooth completion
of the study such as malfunctioning devices or a high
dropout rate of participants. In these cases, we will re-
cruit new participants in order to achieve a total sample
size of 100 participants with complete data, in accord-
ance with the sample size estimation.
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